Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.

Simeone P, Liani R, Tripaldi R, Di Castelnuovo A, Guagnano MT, Tartaro A, Bonadonna RC, Federico V, Cipollone F, Consoli A, Santilli F.

Nutrients. 2018 Dec 2;10(12). pii: E1872. doi: 10.3390/nu10121872.

2.

Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis.

Simeone P, Boccatonda A, Liani R, Santilli F.

Ageing Res Rev. 2018 Dec;48:51-78. doi: 10.1016/j.arr.2018.09.004. Epub 2018 Sep 29. Review.

PMID:
30273676
3.

Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs.

Patti G, Cavallari I, Andreotti F, Calabrò P, Cirillo P, Denas G, Galli M, Golia E, Maddaloni E, Marcucci R, Parato VM, Pengo V, Prisco D, Ricottini E, Renda G, Santilli F, Simeone P, De Caterina R; Working Group on Thrombosis of the Italian Society of Cardiology.

Nat Rev Cardiol. 2019 Feb;16(2):113-130. doi: 10.1038/s41569-018-0080-2. Review.

PMID:
30250166
4.

Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.

Santilli F, Simeone PG, Guagnano MT, Leo M, Maccarone MT, Di Castelnuovo A, Sborgia C, Bonadonna RC, Angelucci E, Federico V, Cianfarani S, Manzoli L, Davì G, Tartaro A, Consoli A.

Diabetes Care. 2017 Nov;40(11):1556-1564. doi: 10.2337/dc17-0589. Epub 2017 Sep 14.

PMID:
28912305
5.

Oxidant stress as a major determinant of platelet activation in invasive breast cancer.

Ferroni P, Santilli F, Cavaliere F, Simeone P, Costarelli L, Liani R, Tripaldi R, Riondino S, Roselli M, Davi G, Guadagni F.

Int J Cancer. 2017 Feb 1;140(3):696-704. doi: 10.1002/ijc.30488. Epub 2016 Nov 7.

6.

Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus.

Santilli F, Liani R, Di Fulvio P, Formoso G, Simeone P, Tripaldi R, Ueland T, Aukrust P, Davì G.

Thromb Haemost. 2016 Nov 30;116(6):1089-1099. Epub 2016 Oct 6.

PMID:
27709225
7.

Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.

Di Sabatino A, Santilli F, Guerci M, Simeone P, Ardizzone S, Massari A, Giuffrida P, Tripaldi R, Malara A, Liani R, Gurini E, Aronico N, Balduini A, Corazza GR, Davì G.

Thromb Haemost. 2016 Aug 30;116(3):486-95. doi: 10.1160/TH16-02-0167. Epub 2016 Jun 16.

PMID:
27305860
8.

The left atrial appendage: from embryology to prevention of thromboembolism.

Patti G, Pengo V, Marcucci R, Cirillo P, Renda G, Santilli F, Calabrò P, De Caterina AR, Cavallari I, Ricottini E, Parato VM, Zoppellaro G, Di Gioia G, Sedati P, Cicchitti V, Davì G, Golia E, Pariggiano I, Simeone P, Abbate R, Prisco D, Zimarino M, Sofi F, Andreotti F, De Caterina R; Working Group of Thrombosis of the Italian Society of Cardiology.

Eur Heart J. 2017 Mar 21;38(12):877-887. doi: 10.1093/eurheartj/ehw159.

PMID:
27122600
9.

The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications.

Santilli F, Simeone P, D'Ardes D, Davì G.

Hypertens Res. 2016 Jun;39(6):404-6. doi: 10.1038/hr.2016.27. Epub 2016 Mar 17. No abstract available.

PMID:
26984299
10.

Coagulation and infective endocarditis: sooner or later.

Santilli F, Simeone P, Davì G.

Intern Emerg Med. 2015 Aug;10(5):539-41. doi: 10.1007/s11739-015-1258-9. Epub 2015 Jun 2. No abstract available.

PMID:
26033535
11.

Platelets and diabetes mellitus.

Santilli F, Simeone P, Liani R, Davì G.

Prostaglandins Other Lipid Mediat. 2015 Jul;120:28-39. doi: 10.1016/j.prostaglandins.2015.05.002. Epub 2015 May 15. Review.

PMID:
25986598
12.

Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein.

Massa S, Simeone P, Muller A, Benvenuto E, Venuti A, Franconi R.

Hum Gene Ther. 2008 Apr;19(4):354-64. doi: 10.1089/hum.2007.122.

PMID:
18439124
13.

Human papillomavirus type 5 in primary keratinocytes from psoriatic skin.

Simeone P, Teson M, Latini A, Carducci M, Venuti A.

Exp Dermatol. 2005 Nov;14(11):824-9.

PMID:
16232304
14.

Targeting endothelin receptor type A in human cervical carcinoma cells.

Cirilli A, Simeone P, Muller A, Bagnato A, Venuti A.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S72-5.

PMID:
15838364
15.

Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade.

Bagnato A, Cirilli A, Salani D, Simeone P, Muller A, Nicotra MR, Natali PG, Venuti A.

Cancer Res. 2002 Nov 15;62(22):6381-4.

16.

Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma.

Venuti A, Salani D, Cirilli A, Simeone P, Muller A, Flamini S, Padley R, Bagnato A.

Clin Sci (Lond). 2002 Aug;103 Suppl 48:310S-313S.

PMID:
12193111
17.

Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection.

Franconi R, Di Bonito P, Dibello F, Accardi L, Muller A, Cirilli A, Simeone P, Donà MG, Venuti A, Giorgi C.

Cancer Res. 2002 Jul 1;62(13):3654-8.

Supplemental Content

Loading ...
Support Center